Regarding the PD analysis, t‐PGDM/Cre ratios (on Day 1/Step B, Day 4/Step C, and Day 7/Step C) and Ex(t‐PGDM) (on Day 7/Step C) were significantly lower in the treatment versus placebo group; the placebo group also showed a decreasing trend.
1
—
—
Regarding the PD analysis, t‐PGDM/Cre ratios (on Day 1/Step B, Day 4/Step C, and Day 7/Step C) and Ex(t‐PGDM) (on Day 7/Step C) were significantly lower in the treatment versus placebo group; the placebo group also showed a decreasing trend.